PER percheron therapeutics limited
Add to My Watchlist 0.00% ! 0.9¢

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-4

  1. itsagas
    14,699 Posts.
    lightbulb Created with Sketch. 1586
    clock Created with Sketch.
    29/05/24
    09:10
    Post #: 74056615
    Results due Dec 2024 (six month readout)
    Akki read the announcement
    Last edited by itsagas: 29/05/24
    PER Price at posting: 7.2¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch. 2  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Nyrada advances to final cohort in Phase I clinical trial of Xolatryp
right-arrow Created with Sketch.
NEWS Thick zone of high-grade gold mineralisation intersected at Fairview South
right-arrow Created with Sketch.
NEWS Mandalay Resources Discovers High-Grade Skarn and Provides Update on Near Mine Exploration at Björkdal
right-arrow Created with Sketch.
NEWS Agreement to acquire 50% of the Central Tanami Gold Project
right-arrow Created with Sketch.
NEWS Exploration drilling confirms large gold system at Abercromby Gold Project
right-arrow Created with Sketch.
NEWS La Negra delivers growth with exceptional silver equivalent drill results
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.9¢ 		Change
0.000(0.00%) 		Mkt cap ! $9.243M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
24 7729304 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 2352341 8
View Market Depth
Last trade - 10.00am 16/07/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.